. | . |
German-Chinese coronavirus vaccine trial begins in China by Staff Writers Berlin (AFP) Aug 5, 2020 Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday. Seventy-two participants have already received their first dose following approval for the phase 1 trial from Chinese regulatory authorities, BioNTech and Fosun Pharma said in a statement. The vaccine candidate, known as BNT162b1, is one of four based on BioNTech's proprietary mRNA technology. Another, BNT162b2, is being evaluated in a global phase 3 trial conducted by BioNTech and US giant Pfizer which started on July 27. The phase 1 trial in China involves 144 participants who will receive two doses 21 days apart. Those aged 18-55 will be the first to take part, followed by older people. Laboratories around the world are racing to find a vaccine to curb COVID-19, which has claimed more than 700,000 lives and upended the livelihoods of millions. More than 200 candidate vaccines are currently being developed with roughly two dozen at the stage of clinical trials with human volunteers. Several Chinese companies are at the forefront of the global vaccine race, while Russia has said it hopes to be the first in the world to produce a vaccine for the public, with a target date of September. But the medicines will likely face heightened scrutiny given that the regulatory systems in both countries are far more opaque than they are in the West. On top of the BioNTech/Pfizer candidate, two other Western coronavirus vaccines are in final phase three trials: one produced by US biotech firm Moderna and the National Institutes for Health; and the other by the University of Oxford and Britain's AstraZeneca. fec/hmn/spm
National Guard to continue COVID-19 deployments with federal pay cut Washington DC (UPI) Aug 04, 2020 National Guard troops serving coronavirus relief missions throughout the country will have their deployments extended through the end of the year, the White House announced this week. But the extension doesn't come with the funding 42 U.S. governors asked for Monday. Per a White House memo issued Monday night, the federal government will only fully fund deployments to Florida and Texas. Most other states will have federal funding terminated by Aug. 21, with the federal government ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |